Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist that reduces appetite and improves glucose control, while creatine is a widely used supplement that enhances muscle performance and mass
Everything you need to achieve lasting results: medical guidance, personalized coaching, and a supportive community
For weight management, GLP-1 binds central GLP-1 receptors inside hypothalamus to enhance satiety signal, delays gastric emptying and gastrointestinal peristalsis to prolong stomach fullness, naturally reducing daily food intake and cumulative calorie surplus
Because it is compounded, the exact strengths and schedule vary by pharmacy and prescriber
doi: 10.2337/dc22-1127 20
His expertise allows for precise administration tailored to each patients biochemical profile and therapeutic objectives